Biology subjects

Albuquerque, G. R.

Publications and source records attributed to Albuquerque, G. R..

4 recordsLinked to original sources

bioRxiv2026

Upregulation of distinct miRNAs in SARS-CoV-2 infected individuals: A differential signature of circulating miRNAs

COVID-19 exhibits a broad clinical spectrum, from asymptomatic to severe cases, underscoring the need for molecular biomarkers to support surveillance and early intervention. Here, we profiled circulating microRNAs (miRNAs) in plasma samples from individuals with asymptomatic/mild COVID-19 and uninfected controls. Seven miRNAs were significantly upregulated in infected patients (miR-126, miR-146b-5p, miR-223-5p, miR-144-3p, miR-22, miR-146a, and miR-30c). ROC curve analysis revealed heterogeneous diagnostic performance: miR-30c achieved the highest overall discriminatory accuracy (AUC = 0.771) with maximum sensitivity (100.0%), while miR-126 provided the highest specificity (100.0%, AUC = 0.763). Other miRNAs, including miR-146b-5p, miR-223-5p, miR-146a, miR-144-3p, and miR-22, showed intermediate accuracy (AUCs 0.684-0.719), whereas miR-21-5p and miR-155 displayed limited discriminatory power (AUCs 0.606 and 0.517, respectively). Predictive interaction network analysis indicated that the upregulated miRNAs target key immune-related genes (CXCL12, IRAK1, TRAF6, STAT1, JAK1, NOTCH1, SMAD4, and BCL2L11), and functional enrichment revealed convergence with transcriptomic profiles from SARS-CoV-2-infected Calu-3 cells, including FOXO3, JAK2, STAT1, and SIRT1. Collectively, these findings point out for potential miRNA signatures associated with mild, non-hospitalized COVID-19 in a predominantly vaccinated cohort but requiring further investigation as molecular markers of early host responses in larger, independent, and clinically diverse cohorts. ImportanceCOVID-19 produces a wide range of outcomes, from no symptoms to severe illness, and clinicians still lack simple molecular tools to help identify infections or anticipate a patients course early in the disease. miRNAs are small molecules circulating in blood that help control gene activity, and because their levels change during infection, they can be considered potential biomarkers candidates for blood-based tests. Here, we measured nine circulating miRNAs in individuals with mild COVID-19 and in uninfected individuals, thus finding that seven of them were consistently higher in infected patients, with some distinguishing the two groups quite well. This study also links these miRNAs to genes involved in the immune response against SARS-CoV-2. Our findings, generated in a modestly sized cohort, support further investigation of blood-based microRNA panels as potential candidates to help identify infection and clarify early host responses to SARS-CoV-2, pending validation in larger and more clinically diverse cohorts.

microbiology↗

bioRxiv2021

Fast surveillance response and genome sequencing reveals the circulation of a new Yellow Fever Virus sublineage in 2021, in Minas Gerais, Brazil

Yellow fever virus (YFV) exhibits a sylvatic cycle of transmission involving wild mosquitoes and non-human primates (NHP). In Brazil, YFV is endemic in the Amazon region, from where waves of epidemic expansion towards other Brazilian states eventually occur. During such waves, the virus usually follows the route from North to the Central-West and Southeast Brazilian regions. Amidst these journeys, outbreaks of Yellow Fever (YF) in NHPs, with spillovers to humans have been observed. In the present work, we describe a surveillance effort encompassing the technology of smartphone applications and the coordinated action of several research institutions and health services that succeeded in the first confirmation of YFV in NHPs in the state of Minas Gerais (MG), Southeast region, in 2021, followed by genome sequencing in an interval of only ten days. Samples from two NHPs (one of the species Alouatta caraya in the municipality of Icarai de Minas and the other of the species Callithrix penicillata in the municipality of Ubai) were collected and the presence of YFV was confirmed by RT-qPCR. We generated three near-complete by Nanopore sequencer MinION. Phylogenetic analysis revealed that all viral genomes recovered are equal and related to lineage South America 1, clustering with a genome detected in the Amazon region (Para state) in 2017. These findings reveal the occurrence of a new wave of viral expansion in MG, six years after the beginning of the major outbreak in the state, between 2015-2018. No human cases were reported to date, showing the importance of coordinated work between local surveillance based on available technologies and support laboratories to ensure a quick response and implementation of contingency measures towards avoiding the occurrence of YF cases in humans.

molecular biology↗

bioRxiv2021

Real-time genomic surveillance during the 2021 re-emergence of the yellow fever virus in Rio Grande do Sul State, Brazil

The yellow fever virus (YFV) re-emergence in Rio Grande do Sul, Brazil, raised big concerns and led the state to declare a Public Health Emergency of State Importance. Here, we generated near-complete genomes from the ongoing outbreak in Southern Brazil, aiming to better understand the phylogenetic aspects and also spatio-temporal dynamics of the virus. Our findings highlight the path and dispersion in Rio Grande do Sul and that YFV was reintroduced from Sao Paulo to the Rio Grande do Sul state through Parana and Santa Catarina states, at the end of 2020.

genomics↗

bioRxiv2021

No evidence of SARS-CoV-2 infection in Neotropical Primates sampled during COVID-19 pandemic in Minas Gerais and Rio Grande do Sul, Brazil.

In 2019, a new coronavirus disease (COVID-19) was detected in China. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was capable to infect domestic and captive mammals like cats, tigers and minks. Due to genetic similarities, concern about the infection of Non-Human Primates (NHPs) and the establishment of a sylvatic cycle has grown in the Americas. In this study, neotropical primates (NP) were sampled in different areas from Brazil to investigate whether they were infected by SARS-CoV-2. A total of 89 samples from 51 NP of four species were examined. No positive samples were detected via RT-qPCR, regardless of the NHP species, tissue or habitat tested. This work provides the first report on the lack of evidence of circulation of SARS-CoV-2 in NP. The expand of wild animals sampling is necessary to understand their role in the epidemiology of SARS-CoV-2.

microbiology↗